These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12553069)

  • 1. Perspectives for antitumor therapy based on the recognition mechanism by which macrophages identify undesirable foreign and native cells and molecules.
    Takiguchi K; Inagawa H; Nishizawa T; Kohchi C; Soma G
    Anticancer Res; 2002; 22(6C):4277-80. PubMed ID: 12553069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using activated macrophages for tumor therapy? Priv.-Doz. Dr. R. Andreesen presents new perspectives in cancer research. Interview by Elisabeth B. Moosmann].
    Andreesen R
    Fortschr Med; 1991 Apr; 109(12):21-2. PubMed ID: 1855752
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune responses to human tumors: development of tumor vaccines.
    Platsoucas CD; Fincke JE; Pappas J; Jung WJ; Heckel M; Schwarting R; Magira E; Monos D; Freedman RS
    Anticancer Res; 2003; 23(3A):1969-96. PubMed ID: 12894571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
    Zhang T; Barber A; Sentman CL
    Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of tumor-associated macrophages.
    Yuan A; Chen JJ; Yang PC
    Adv Clin Chem; 2008; 45():199-223. PubMed ID: 18429498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharide.
    Hino M; Kohchi C; Nishizawa T; Yoshida A; Nakata K; Inagawa H; Hori H; Makino K; Terada H; Soma G
    Anticancer Res; 2005; 25(6A):3747-54. PubMed ID: 16302735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poxviruses as vectors for cancer immunotherapy.
    Kwak H; Hörig H; Kaufman HL
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):161-8. PubMed ID: 12669450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing immune responses for cancer therapy.
    Xue SA; Stauss HJ
    Cell Mol Immunol; 2007 Jun; 4(3):173-84. PubMed ID: 17601371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.
    Singh NP; Yolcu ES; Taylor DD; Gercel-Taylor C; Metzinger DS; Dreisbach SK; Shirwan H
    Cancer Res; 2003 Jul; 63(14):4067-73. PubMed ID: 12874008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered macrophage differentiation and immune dysfunction in tumor development.
    Sica A; Bronte V
    J Clin Invest; 2007 May; 117(5):1155-66. PubMed ID: 17476345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for "weapons of mass destruction" for cancer -- immuno/ gene therapy comes of age.
    Wei MQ; Metharom P; Ellem KA; Barth S
    Cell Mol Immunol; 2005 Oct; 2(5):351-7. PubMed ID: 16368061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of macrophages in anticancer therapy: the macrophage network theory.
    Kohchi C; Inagawa H; Hino M; Oda M; Nakata K; Yoshida A; Hori H; Terada H; Makino K; Takiguchi K; Soma G
    Anticancer Res; 2004; 24(5C):3311-20. PubMed ID: 15515426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
    Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
    J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.